NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN USA, AUSTRALIA, CANADA, HONG KONG, JAPAN OR SOUTH AFRICA. On 30 April 2014, Hemfosa Fastigheter announced that it had issued unsecured bond loans with a tenor of three years. The loans amount to SEK 1,200 million. In accordance with the terms and conditions of the bond loans, Hemfosa has applied for listing of the loans on NASDAQ OMX Stockholm and has also prepared a prospectus for the listing. The prospectus has been approved by the Swedish Financial Supervisory Authority and the estimated listing date of the bond loans is 12 June 2014. The prospectus is now available at www.hemfosa.se. The publication of the prospectus or the application for listing of the bond loans on NASDAQ OMX Stockholm do not contain or constitute an offer to subscribe for or acquire bonds but are a consequence of the terms and conditions of the bond loans. For more information, please visit www.hemfosa.se or contact: Jens Engwall, CEO, jens.engwall@hemfosa.se, mobile: +46 706 90 6550 Karin Osslind, CFO, karin.osslind@hemfosa.se, mobile: +46 707 94 9337 Hemfosa Fastigheter AB (publ) discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was released for publication on 11 June 2014 at 1.00 pm. About Hemfosa Fastigheter Hemfosa is a Swedish property company with a property portfolio characterized by a balanced geographic spread and a high proportion of community service properties with the government and municipalities as the largest tenants. This generates stable revenue flows and a healthy yield. Hemfosa also aims to create value by actively participating in the transaction market. Hemfosa owns commercial properties in Sweden with a total property value of approximately SEK 18.5 billion, including the company’s share of the property value in joint ventures. The company’s share is listed on the NASDAQ OMX Stockholm Mid Cap exchange as of 21 March 2014.
Hemfosa applies for listing of bond loans on NASDAQ OMX
Top 10 Most Recent News Articles
BYD's Chip Mastery Amid China's Auto Supply Tensions
Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...
Continue Reading
Midea's VitaBreeze: Revolutionizing Personalized Climate
A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...
Continue Reading
ISO 45010: First Guidance for Menstruation, Menopause
Tackling Menstruation and Menopause in the Workplace Today, the International Organization for Standardization (ISO) has taken a bold step forward by launching ISO 45010—a groundbreaking standard aimed at addressing menstruation and menopause in the workplace. Millions endure these natural processes throughout their careers, yet structured policies to support them have...
Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar
Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...
Continue Reading
Baidu's Stock Connect Inclusion: What It Means for Investors
An Intriguing Move For Baidu's Class A Shares Well, here we go again, folks. Another move on the chessboard for Baidu. They've just walked their Class A ordinary shares onto the Shenzhen-Hong Kong and Shanghai-Hong Kong Stock Connects. As of today, September 7, 2026, mainland investors can now get their mitts on these shares more easily. It might not be a...
Continue Reading
Hyundai and UEFA: Kicking Off a Game-Changing Deal
Hyundai Drives Into Europe's Football Arena Football fever just turned electric with Hyundai allying itself with the UEFA Champions League. We're not talking about sidelines. We're smack dab in the center field of a multi-year partnership starting with the 2026/27 season. Folks, if you think this is just Hyundai shaking hands for brand exposure, think again. This is...
Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts
While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...
Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials
In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...
Continue Reading
York Space Systems Faces Class Action Over Misleading IPO
York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...
Continue Reading
TCL’s AI Vision: Immersive Living at IFA 2026
AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...
Continue ReadingTop 5 Most Recently Viewed Articles
Lynkwell Boosts Growth with Strategic Investments in North America
Lynkwell Amplifies Growth Plans for North American Expansion Lynkwell, a leading player in energy infrastructure, is set to embark on an exciting journey into 2025. With a focus on meeting the growing demands of the evolving electric vehicle (EV) market, Lynkwell is making significant investments to enhance its capabilities and expand its footprint across North America....
Continue Reading
Understanding the Recent Private Student Loan Trends and Insights
Overview of Recent Trends in Private Student Loans In the recent semi-annual Private Student Loan Report released by Enterval Analytics, insights into the current status of private student loans reveal a stable repayment landscape. Since Enterval focuses on the private student loan market, their findings shed light on how borrowers are adapting their financial strategies...
Continue Reading
StemCyte's Groundbreaking RMAT Designation for Long COVID-19
StemCyte's Major Achievement in Cord Blood Therapy StemCyte has made significant strides in regenerative medicine, specifically with its Hematopoietic Progenitor Cell (HPC) Cord Blood therapy. The company recently announced that it has received the Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) aimed at treating...
Continue Reading
Novo Nordisk Restructures to Combat Rising Competition
Novo Nordisk's Significant Job Cuts Novo Nordisk, a leading pharmaceutical company in diabetes care, has announced a major workforce reduction, cutting 9,000 jobs, which amounts to about 11.5% of its employees. This decision reflects the intense market pressure the company faces from its competitor, Eli Lilly. Restructuring for Financial Efficiency The restructuring...
Continue Reading
One Helix: The Innovative Research Hub Transforming Life Sciences
Elevating Research with One Helix One Helix emerges as a landmark project in life sciences, representing a new era of innovation and sustainable architecture. Located within a prominent university medical center, this facility is not just a building; it is a commitment to fostering scientific advancements. Completely leased to AstraZeneca, One Helix is designed to elevate...
Continue Reading